Literature DB >> 16098273

Cosmetic psychopharmacology of anxiety: bioethical considerations.

Dan J Stein1.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16098273     DOI: 10.1007/s11920-005-0072-x

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


× No keyword cloud information.
  10 in total

1.  Palliative psychopharmacology: a putative specialty to optimize the subjective quality of life.

Authors:  B G Charlton
Journal:  QJM       Date:  2003-05

Review 2.  A neuro-evolutionary approach to the anxiety disorders.

Authors:  D J Stein; C Bouwer
Journal:  J Anxiety Disord       Date:  1997 Jul-Aug

3.  Is better best? A noted ethicist argues in favor of brain enhancement.

Authors:  Arthur L Caplan
Journal:  Sci Am       Date:  2003-09       Impact factor: 2.142

4.  The quest for a smart pill.

Authors:  Stephen S Hall
Journal:  Sci Am       Date:  2003-09       Impact factor: 2.142

5.  The economic burden of anxiety disorders in the 1990s.

Authors:  P E Greenberg; T Sisitsky; R C Kessler; S N Finkelstein; E R Berndt; J R Davidson; J C Ballenger; A J Fyer
Journal:  J Clin Psychiatry       Date:  1999-07       Impact factor: 4.384

6.  Philosophy of psychopharmacology.

Authors:  D J Stein
Journal:  Perspect Biol Med       Date:  1998       Impact factor: 1.416

7.  Selective alteration of personality and social behavior by serotonergic intervention.

Authors:  B Knutson; O M Wolkowitz; S W Cole; T Chan; E A Moore; R C Johnson; J Terpstra; R A Turner; V I Reus
Journal:  Am J Psychiatry       Date:  1998-03       Impact factor: 18.112

8.  Is better always good? The Enhancement Project.

Authors:  E Parens
Journal:  Hastings Cent Rep       Date:  1998 Jan-Feb       Impact factor: 2.683

9.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

Authors:  R C Kessler; K A McGonagle; S Zhao; C B Nelson; M Hughes; S Eshleman; H U Wittchen; K S Kendler
Journal:  Arch Gen Psychiatry       Date:  1994-01

10.  Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder.

Authors:  Lewis L Judd; Mark Hyman Rapaport; Kimberly A Yonkers; A John Rush; Ellen Frank; Michael E Thase; David J Kupfer; John M Plewes; Pamela J Schettler; Gary Tollefson
Journal:  Am J Psychiatry       Date:  2004-10       Impact factor: 18.112

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.